Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of oral nicotinamide therapy for preeclampsia
jRCTs021180005Completed
- Sponsor
- Ministry of Education, Culture, Sports, Science and Technology
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nicotinamide in preeclampsia, sponsored by Ministry of Education, Culture, Sports, Science and Technology. Primary endpoint: Prolongation of gestational period. Started Mar 2021; status: completed.
02
Drugs
nicotinamide
03
Conditions
preeclampsia
Beyond the preview
Go deeper on jRCTs021180005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180005.